These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7933247)

  • 21. Screening for prostate cancer remains controversial.
    Stark JR; Mucci L; Rothman KJ; Adami HO
    BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
    [No Abstract]   [Full Text] [Related]  

  • 22. Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part III: Management strategies and outcomes.
    Barry MJ; Fleming C; Coley CM; Wasson JH; Fahs MC; Oesterling JE
    Urology; 1995 Sep; 46(3):277-89. PubMed ID: 7544931
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostate cancer screening and mortality: comparison of recent randomized controlled clinical trials.
    Mian BM
    Urol Oncol; 2010; 28(3):233-6. PubMed ID: 20097584
    [No Abstract]   [Full Text] [Related]  

  • 24. Does early detection of prostate cancer offer more good than harm?
    Feightner JW
    Can J Oncol; 1994 Nov; 4 Suppl 1():74-5. PubMed ID: 8853495
    [No Abstract]   [Full Text] [Related]  

  • 25. The prostate cancer treatment bazaar: comment on "Physician visits prior to treatment for clinically localized prostate cancer".
    Barry MJ
    Arch Intern Med; 2010 Mar; 170(5):450-2. PubMed ID: 20212181
    [No Abstract]   [Full Text] [Related]  

  • 26. [Screening for cancer of the prostate: a life-saver or a waste of money?].
    Rutishauser G; Graber P; Leisinger HJ; Schmid HP
    Ann Urol (Paris); 1994; 28(4):176-7. PubMed ID: 7979206
    [No Abstract]   [Full Text] [Related]  

  • 27. Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction.
    Boer R; Schröder FH
    Prostate; 1999 Jul; 40(2):130-4. PubMed ID: 10386474
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison of four treatment options for low-risk prostate cancer: Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or "early intermediate" risk (PREFERE) - trial AP 65/11 of the AUO].
    Rexer H; Bussar-Maatz R
    Urologe A; 2015 May; 54(5):723-5. PubMed ID: 25802104
    [No Abstract]   [Full Text] [Related]  

  • 29. The American Cancer Society National Prostate Cancer Detection Project and National patterns of prostate cancer detection and treatment.
    Mettlin C
    CA Cancer J Clin; 1997; 47(5):265-72. PubMed ID: 9314821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for prostate cancer. Early screening is important despite lack of data from trials.
    Catalona WJ
    BMJ; 1997 Jul; 315(7101):187. PubMed ID: 9251561
    [No Abstract]   [Full Text] [Related]  

  • 31. The Scandinavian Prostate Cancer Group Study: the case for conservative management.
    Parker C
    BJU Int; 2005 Nov; 96(7):952-3. PubMed ID: 16225505
    [No Abstract]   [Full Text] [Related]  

  • 32. SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care.
    Wilt TJ
    J Natl Cancer Inst; 2008 Aug; 100(16):1123-5. PubMed ID: 18695131
    [No Abstract]   [Full Text] [Related]  

  • 33. Surgery no better than observation for localized prostate cancer.
    Printz C
    Cancer; 2012 Nov; 118(22):5452-3. PubMed ID: 23129387
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer screening: the need for problem-solving that puts men's interests first.
    Holmberg L
    Eur Urol; 2009 Jul; 56(1):34-7. PubMed ID: 19394132
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness of prostate specific antigen screening in the United States: extrapolating from the European study of screening for prostate cancer.
    Shteynshlyuger A; Andriole GL
    J Urol; 2011 Mar; 185(3):828-32. PubMed ID: 21239021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In depth analysis of 2 studies of prostate cancer screening--what makes sense?].
    Recker F
    Praxis (Bern 1994); 2010 Feb; 99(3):183-5. PubMed ID: 20127638
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
    Schröder FH; Roobol MJ
    BJU Int; 2009 Jan; 103(2):143-4. PubMed ID: 19076150
    [No Abstract]   [Full Text] [Related]  

  • 38. Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?
    Prasad V
    Med Hypotheses; 2016 Aug; 93():71-3. PubMed ID: 27372859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A misleading paper on prostate cancer screening.
    Elwood M
    Prostate; 2004 Dec; 61(4):372; author reply 373-4. PubMed ID: 15503318
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostate cancer screening--time to abandon one-size-fits-all approach?
    Kim J; Davis JW
    JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.